4/A
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-045113
Chief Development Officer sold 11,537 shares at $3.16 ($36,503)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Machatha Stephen Chief Development Officer | 2024-03-12 | Sale | −11,537 | $3.16 | $36,503 | 252,812 | D |
| Open-market sales · 11,537 sh · avg $3.16 · $36,503 | |||||||
Loading xslF345X05/ownership.xml…